Getting melanoma cells to stimulate with frequency

被引：2

作者：

Carson, WE ^{[1
]}

机构：

[1] Ohio State Univ, Coll Med, Columbus, OH 43210 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 35期

关键词：

D O I：

10.1200/JCO.2005.03.8307

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：8929 / 8931

页数：3

相关论文

共 11 条

[1]

CHANG DZ, 2004, AM SOC HEMATOL ED PR, V9, P207

[2]

Disis ML, 1996, BLOOD, V88, P202

[3] VACCINATION WITH IRRADIATED TUMOR-CELLS ENGINEERED TO SECRETE MURINE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR STIMULATES POTENT, SPECIFIC, AND LONG-LASTING ANTITUMOR IMMUNITY [J].

DRANOFF, G ;

JAFFEE, E ;

LAZENBY, A ;

GOLUMBEK, P ;

LEVITSKY, H ;

BROSE, K ;

JACKSON, V ;

HAMADA, H ;

PARDOLL, D ;

MULLIGAN, RC .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) :3539-3543

[4] Prolonged survival after complete resection of disseminated melanoma and active immunotherapy with a therapeutic cancer vaccine [J].

Hsueh, EC ;

Essner, R ;

Foshag, LJ ;

Ollila, DW ;

Gammon, G ;

O'Day, SJ ;

Boasberg, PD ;

Stern, SL ;

Ye, X ;

Morton, DL .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (23) :4549-4554

[5]

Lee K A, 2001, J Assoc Nurses AIDS Care, V12 Suppl, P19, DOI 10.1016/S1055-3290(06)60154-4

[6] Immunogenicity, including vitiligo, and feasibility of vaccination with autologous GM-CSF-transduced tumor cells in metastatic melanoma patients [J].

Luiten, RM ;

Kueter, EWM ;

Mooi, W ;

Gallee, MPW ;

Rankin, EM ;

Gerritsen, WR ;

Clift, SM ;

Nooijen, WJ ;

Weder, P ;

van de Kasteele, WF ;

Sein, J ;

van den Berk, PCM ;

Nieweg, OE ;

Berns, AM ;

Spits, H ;

de Gast, GC .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (35) :8978-8991

[7] Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells [J].

Slingluff, CL ;

Petroni, GR ;

Yamshchikov, GV ;

Barnd, DL ;

Eastham, S ;

Galavotti, H ;

Patterson, JW ;

Deacon, DH ;

Hibbitts, S ;

Teates, D ;

Neese, PY ;

Grosh, WW ;

Chianese-Bullock, KA ;

Woodson, EMH ;

Wiernasz, CJ ;

Merrill, P ;

Gibson, J ;

Ross, M ;

Engelhard, VH .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (21) :4016-4026

[8] Immunologic and clinical outcomes of vaccination with a multiepitope melanoma peptide vaccine plus low-dose interleukin-2 administered either concurrently or on a delayed schedule [J].

Slingluff, CL ;

Petroni, GR ;

Yamshchikov, GV ;

Hibbitts, S ;

Grosh, WW ;

Chianese-Bullock, KA ;

Bissonette, EA ;

Barnd, DL ;

Deacon, DH ;

Patterson, JW ;

Parekh, J ;

Neese, PY ;

Woodson, EMH ;

Wiernasz, CJ ;

Merrill, P .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (22) :4474-4485

[9] Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma [J].

Soiffer, R ;

Hodi, FS ;

Haluska, F ;

Jung, K ;

Gillessen, S ;

Singer, S ;

Tanabe, K ;

Duda, R ;

Mentzer, S ;

Jaklitsch, M ;

Bueno, R ;

Clift, S ;

Hardy, S ;

Neuberg, D ;

Mulligan, R ;

Webb, I ;

Mihm, M ;

Dranoff, G .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (17) :3343-3350

[10]

Vaishampayan U, 2002, CLIN CANCER RES, V8, P3696